Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries.
The global Albumin (as Excipient) market size was valued at US$ 4762 million in 2023 and is forecast to a readjusted size of USD 7108 million by 2030 with a CAGR of 6.0% during review period.
The industry"s leading manufacturers are Grifols, CSL and Takeda, which accounted for 20.39%, 15.19% and 14.36% of global revenues in 2019.
By region, Asia-Pacific is the largest consumption market of Albumin (as Excipient), with its sales volume at 70.83%.
This report is a detailed and comprehensive analysis for global Albumin (as Excipient) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Albumin (as Excipient) market size and forecasts, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2019-2030
Global Albumin (as Excipient) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2019-2030
Global Albumin (as Excipient) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2019-2030
Global Albumin (as Excipient) market shares of main players, shipments in revenue ($ Million), sales quantity (MT), and ASP (USD/Kg), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Albumin (as Excipient)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Albumin (as Excipient) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CSL, Grifols, Takeda, Octapharma, Hualan Bio, CBPO, Shanghai RAAS, Kedrion, LFB Group, Albumedix, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
Albumin (as Excipient) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Human Serum Albumin
Recombinant Albumin
麻豆原创 segment by Application
Cell Culture Media
Medical Supplements
Therapeutics
Major players covered
CSL
Grifols
Takeda
Octapharma
Hualan Bio
CBPO
Shanghai RAAS
Kedrion
LFB Group
Albumedix
Biotest
Merck
Ventria (InVitria)
HiMedia
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Albumin (as Excipient) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Albumin (as Excipient), with price, sales quantity, revenue, and global market share of Albumin (as Excipient) from 2019 to 2024.
Chapter 3, the Albumin (as Excipient) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Albumin (as Excipient) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Albumin (as Excipient) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Albumin (as Excipient).
Chapter 14 and 15, to describe Albumin (as Excipient) sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Albumin (as Excipient) Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Human Serum Albumin
1.3.3 Recombinant Albumin
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Albumin (as Excipient) Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Cell Culture Media
1.4.3 Medical Supplements
1.4.4 Therapeutics
1.5 Global Albumin (as Excipient) 麻豆原创 Size & Forecast
1.5.1 Global Albumin (as Excipient) Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Albumin (as Excipient) Sales Quantity (2019-2030)
1.5.3 Global Albumin (as Excipient) Average Price (2019-2030)
2 Manufacturers Profiles
2.1 CSL
2.1.1 CSL Details
2.1.2 CSL Major Business
2.1.3 CSL Albumin (as Excipient) Product and Services
2.1.4 CSL Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 CSL Recent Developments/Updates
2.2 Grifols
2.2.1 Grifols Details
2.2.2 Grifols Major Business
2.2.3 Grifols Albumin (as Excipient) Product and Services
2.2.4 Grifols Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 Grifols Recent Developments/Updates
2.3 Takeda
2.3.1 Takeda Details
2.3.2 Takeda Major Business
2.3.3 Takeda Albumin (as Excipient) Product and Services
2.3.4 Takeda Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 Takeda Recent Developments/Updates
2.4 Octapharma
2.4.1 Octapharma Details
2.4.2 Octapharma Major Business
2.4.3 Octapharma Albumin (as Excipient) Product and Services
2.4.4 Octapharma Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Octapharma Recent Developments/Updates
2.5 Hualan Bio
2.5.1 Hualan Bio Details
2.5.2 Hualan Bio Major Business
2.5.3 Hualan Bio Albumin (as Excipient) Product and Services
2.5.4 Hualan Bio Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 Hualan Bio Recent Developments/Updates
2.6 CBPO
2.6.1 CBPO Details
2.6.2 CBPO Major Business
2.6.3 CBPO Albumin (as Excipient) Product and Services
2.6.4 CBPO Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 CBPO Recent Developments/Updates
2.7 Shanghai RAAS
2.7.1 Shanghai RAAS Details
2.7.2 Shanghai RAAS Major Business
2.7.3 Shanghai RAAS Albumin (as Excipient) Product and Services
2.7.4 Shanghai RAAS Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 Shanghai RAAS Recent Developments/Updates
2.8 Kedrion
2.8.1 Kedrion Details
2.8.2 Kedrion Major Business
2.8.3 Kedrion Albumin (as Excipient) Product and Services
2.8.4 Kedrion Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.8.5 Kedrion Recent Developments/Updates
2.9 LFB Group
2.9.1 LFB Group Details
2.9.2 LFB Group Major Business
2.9.3 LFB Group Albumin (as Excipient) Product and Services
2.9.4 LFB Group Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.9.5 LFB Group Recent Developments/Updates
2.10 Albumedix
2.10.1 Albumedix Details
2.10.2 Albumedix Major Business
2.10.3 Albumedix Albumin (as Excipient) Product and Services
2.10.4 Albumedix Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.10.5 Albumedix Recent Developments/Updates
2.11 Biotest
2.11.1 Biotest Details
2.11.2 Biotest Major Business
2.11.3 Biotest Albumin (as Excipient) Product and Services
2.11.4 Biotest Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.11.5 Biotest Recent Developments/Updates
2.12 Merck
2.12.1 Merck Details
2.12.2 Merck Major Business
2.12.3 Merck Albumin (as Excipient) Product and Services
2.12.4 Merck Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.12.5 Merck Recent Developments/Updates
2.13 Ventria (InVitria)
2.13.1 Ventria (InVitria) Details
2.13.2 Ventria (InVitria) Major Business
2.13.3 Ventria (InVitria) Albumin (as Excipient) Product and Services
2.13.4 Ventria (InVitria) Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.13.5 Ventria (InVitria) Recent Developments/Updates
2.14 HiMedia
2.14.1 HiMedia Details
2.14.2 HiMedia Major Business
2.14.3 HiMedia Albumin (as Excipient) Product and Services
2.14.4 HiMedia Albumin (as Excipient) Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.14.5 HiMedia Recent Developments/Updates
3 Competitive Environment: Albumin (as Excipient) by Manufacturer
3.1 Global Albumin (as Excipient) Sales Quantity by Manufacturer (2019-2024)
3.2 Global Albumin (as Excipient) Revenue by Manufacturer (2019-2024)
3.3 Global Albumin (as Excipient) Average Price by Manufacturer (2019-2024)
3.4 麻豆原创 Share Analysis (2023)
3.4.1 Producer Shipments of Albumin (as Excipient) by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2023
3.4.2 Top 3 Albumin (as Excipient) Manufacturer 麻豆原创 Share in 2023
3.4.3 Top 6 Albumin (as Excipient) Manufacturer 麻豆原创 Share in 2023
3.5 Albumin (as Excipient) 麻豆原创: Overall Company Footprint Analysis
3.5.1 Albumin (as Excipient) 麻豆原创: Region Footprint
3.5.2 Albumin (as Excipient) 麻豆原创: Company Product Type Footprint
3.5.3 Albumin (as Excipient) 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Albumin (as Excipient) 麻豆原创 Size by Region
4.1.1 Global Albumin (as Excipient) Sales Quantity by Region (2019-2030)
4.1.2 Global Albumin (as Excipient) Consumption Value by Region (2019-2030)
4.1.3 Global Albumin (as Excipient) Average Price by Region (2019-2030)
4.2 North America Albumin (as Excipient) Consumption Value (2019-2030)
4.3 Europe Albumin (as Excipient) Consumption Value (2019-2030)
4.4 Asia-Pacific Albumin (as Excipient) Consumption Value (2019-2030)
4.5 South America Albumin (as Excipient) Consumption Value (2019-2030)
4.6 Middle East & Africa Albumin (as Excipient) Consumption Value (2019-2030)
5 麻豆原创 Segment by Type
5.1 Global Albumin (as Excipient) Sales Quantity by Type (2019-2030)
5.2 Global Albumin (as Excipient) Consumption Value by Type (2019-2030)
5.3 Global Albumin (as Excipient) Average Price by Type (2019-2030)
6 麻豆原创 Segment by Application
6.1 Global Albumin (as Excipient) Sales Quantity by Application (2019-2030)
6.2 Global Albumin (as Excipient) Consumption Value by Application (2019-2030)
6.3 Global Albumin (as Excipient) Average Price by Application (2019-2030)
7 North America
7.1 North America Albumin (as Excipient) Sales Quantity by Type (2019-2030)
7.2 North America Albumin (as Excipient) Sales Quantity by Application (2019-2030)
7.3 North America Albumin (as Excipient) 麻豆原创 Size by Country
7.3.1 North America Albumin (as Excipient) Sales Quantity by Country (2019-2030)
7.3.2 North America Albumin (as Excipient) Consumption Value by Country (2019-2030)
7.3.3 United States 麻豆原创 Size and Forecast (2019-2030)
7.3.4 Canada 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Mexico 麻豆原创 Size and Forecast (2019-2030)
8 Europe
8.1 Europe Albumin (as Excipient) Sales Quantity by Type (2019-2030)
8.2 Europe Albumin (as Excipient) Sales Quantity by Application (2019-2030)
8.3 Europe Albumin (as Excipient) 麻豆原创 Size by Country
8.3.1 Europe Albumin (as Excipient) Sales Quantity by Country (2019-2030)
8.3.2 Europe Albumin (as Excipient) Consumption Value by Country (2019-2030)
8.3.3 Germany 麻豆原创 Size and Forecast (2019-2030)
8.3.4 France 麻豆原创 Size and Forecast (2019-2030)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Russia 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Italy 麻豆原创 Size and Forecast (2019-2030)
9 Asia-Pacific
9.1 Asia-Pacific Albumin (as Excipient) Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Albumin (as Excipient) Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Albumin (as Excipient) 麻豆原创 Size by Region
9.3.1 Asia-Pacific Albumin (as Excipient) Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Albumin (as Excipient) Consumption Value by Region (2019-2030)
9.3.3 China 麻豆原创 Size and Forecast (2019-2030)
9.3.4 Japan 麻豆原创 Size and Forecast (2019-2030)
9.3.5 South Korea 麻豆原创 Size and Forecast (2019-2030)
9.3.6 India 麻豆原创 Size and Forecast (2019-2030)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2019-2030)
9.3.8 Australia 麻豆原创 Size and Forecast (2019-2030)
10 South America
10.1 South America Albumin (as Excipient) Sales Quantity by Type (2019-2030)
10.2 South America Albumin (as Excipient) Sales Quantity by Application (2019-2030)
10.3 South America Albumin (as Excipient) 麻豆原创 Size by Country
10.3.1 South America Albumin (as Excipient) Sales Quantity by Country (2019-2030)
10.3.2 South America Albumin (as Excipient) Consumption Value by Country (2019-2030)
10.3.3 Brazil 麻豆原创 Size and Forecast (2019-2030)
10.3.4 Argentina 麻豆原创 Size and Forecast (2019-2030)
11 Middle East & Africa
11.1 Middle East & Africa Albumin (as Excipient) Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Albumin (as Excipient) Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Albumin (as Excipient) 麻豆原创 Size by Country
11.3.1 Middle East & Africa Albumin (as Excipient) Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Albumin (as Excipient) Consumption Value by Country (2019-2030)
11.3.3 Turkey 麻豆原创 Size and Forecast (2019-2030)
11.3.4 Egypt 麻豆原创 Size and Forecast (2019-2030)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2019-2030)
11.3.6 South Africa 麻豆原创 Size and Forecast (2019-2030)
12 麻豆原创 Dynamics
12.1 Albumin (as Excipient) 麻豆原创 Drivers
12.2 Albumin (as Excipient) 麻豆原创 Restraints
12.3 Albumin (as Excipient) Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Albumin (as Excipient) and Key Manufacturers
13.2 Manufacturing Costs Percentage of Albumin (as Excipient)
13.3 Albumin (as Excipient) Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Albumin (as Excipient) Typical Distributors
14.3 Albumin (as Excipient) Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
听
听
*If Applicable.
